InvestorsHub Logo
Followers 71
Posts 11465
Boards Moderated 0
Alias Born 12/25/2009

Re: None

Friday, 07/14/2017 8:25:23 AM

Friday, July 14, 2017 8:25:23 AM

Post# of 1047
BTIG Starts Eiger BioPharma (EIGR) at Buy

July 14, 2017 7:31 AM EDT

BTIG initiates coverage on Eiger BioPharma (NASDAQ: EIGR) with a Buy rating and a price target of $32.00.Analyst Robert Hazlett

_________________________________________________________

Consensus Ratings for Eiger BioPharmaceuticals (NASDAQ:EIGR) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating: Buy (Score: 3.00)
Consensus Price Target: $32.75 (339.60% upside)
_________________________________________________________

https://www.marketbeat.com/stocks/NASDAQ/EIGR/

EIGR